Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome.
about
Biomarkers for ectopic pregnancy and pregnancy of unknown locationLive birth is the correct outcome for clinical trials evaluating therapy for the infertile coupleDiagnostic value of serum hCG on the outcome of pregnancy of unknown location: a systematic review and meta-analysis.Diagnosing ectopic pregnancy and current concepts in the management of pregnancy of unknown location.Evaluation of ADAM-12 as a diagnostic biomarker of ectopic pregnancy in women with a pregnancy of unknown location.Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study.Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown LocationShotgun proteomics identifies serum fibronectin as a candidate diagnostic biomarker for inclusion in future multiplex tests for ectopic pregnancyA unique case of ruptured ectopic pregnancy in a patient with negative preg-nancy test - a case report and brief review of the literature.Ectopic pregnancy prediction in women with a pregnancy of unknown location: data beyond 48 h are necessary.Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules.Reduced Ectopic Pregnancy Rate on Day 5 Embryo Transfer Compared with Day 3: A Meta-Analysis.The Diagnosis and Treatment of Ectopic Pregnancy.Early pregnancy failure: beware of the pitfalls of modern management.Validation of a clinical risk scoring system, based solely on clinical presentation, for the management of pregnancy of unknown locationFollowing declining human chorionic gonadotropin values in pregnancies of unknown location: when is it safe to stop?The clinical performance of the M4 decision support model to triage women with a pregnancy of unknown location as at low or high risk of complications.Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicityPredicting the decline in human chorionic gonadotropin in a resolving pregnancy of unknown location.The term "pregnancy of unknown location" is here to stay.Pregnancies of unknown location: update on nomenclature and final outcomesPregnancy of unknown location.Serum biomarkers for ectopic pregnancy diagnosis.Time to revisit the human chorionic gonadotropin discriminatory level in the management of pregnancy of unknown location.Key Concepts in Pregnancy of Unknown Location: Identifying Ectopic Pregnancy and Providing Patient-Centered Care.Pitfalls and tips in the diagnosis of ectopic pregnancy.Association between three-dimensional transvaginal sonographic markers and outcome of pregnancy of unknown location: a pilot study.Factors to consider in pregnancy of unknown location.Does the presence of a Caesarean section scar affect implantation site and early pregnancy outcome in women attending an early pregnancy assessment unit?Rationalizing the management of pregnancies of unknown location: temporal and external validation of a risk prediction model on 1962 pregnancies.Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two-step triage protocol.Predicting first trimester pregnancy outcome: derivation of a multiple marker test.Differences in Serum Human Chorionic Gonadotropin Rise in Early Pregnancy by Race and Value at Presentation.AIUM practice guideline for the performance of obstetric ultrasound examinations.Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.The term 'Pregnancy of unknown location' is staying put.Can risk factors, clinical history and symptoms be used to predict risk of ectopic pregnancy in women attending an early pregnancy assessment unit?Minimising harm in the early pregnancy population.A missed opportunity for excellence: the NICE guideline on the diagnosis and initial management of ectopic pregnancy and miscarriage.
P2860
Q27025112-C322F175-2166-41A2-BBEF-D0247D3680C4Q33694204-1F057869-8E23-4D1C-86BE-AC515F317D1FQ34298080-AA0BE4BB-E770-4A64-892D-789049F097D9Q34375947-53A4F4C9-2834-47F4-8850-139E20896BDDQ34395372-0A41BE6E-5503-4FEE-8379-28AA803803EBQ34569880-3FF1F0AD-6318-4176-A90A-F442E79714F3Q34793000-F7055148-72A1-4F91-8BCD-D6771863877CQ34796295-12564FBC-0F72-4C74-B8AF-9C47D5EBBEB7Q35022146-5B950CCB-8E70-441E-8F7A-4DD2FB4963BCQ35071675-ED0FA329-293C-4061-8D8F-FD6056F7689EQ35635090-C7C0051C-C4EE-4BD9-ABCB-1924943E2370Q36259663-B5276FA6-A03C-47C2-9358-C3C91E5995D3Q36275228-286541D7-5098-47E7-A64A-0C0607BF5D69Q36343202-CB797212-FF48-4B77-83FD-E825D7131986Q36501819-7ADDFEE7-1001-4774-A69C-130FA390E18EQ36767577-9F5ACFC5-B6D2-47A0-8E2F-0C2519323F36Q36991848-C105ED2D-A725-4485-98A0-020536C93B51Q37029975-F368456F-43BE-4E41-AEFD-D716E940C111Q37063399-8138CABC-2A93-4890-9CB4-B76D2179F5B1Q37117410-EE6689D3-91D0-4D71-B1D1-97B7C01077B2Q37259158-78779029-4B40-4032-82A3-1DD77053898DQ37259641-D66ED902-775D-4992-9B25-BC377F31023DQ37437432-A4C3F26F-3D7F-4B92-8077-CEACA93F40FBQ38088388-35CDB6D0-AE61-4301-83D9-01966DCA03C0Q38190933-AAABE3BC-E33D-4E63-83CA-4A8E4AF4C491Q38990335-F74DD367-77B9-4B9F-81A0-10670B561EC7Q39112890-6ACC591C-31C5-4588-A851-B42B8B39985CQ39181210-CFA5F89C-8C62-4F94-8EC7-B01599288522Q39404296-10862E44-DC78-412E-A0E1-B280B3E46AA2Q39435373-79416BBC-D742-498A-88D7-3FD4C11BD4EFQ40084198-9A645DEA-781C-48C5-8FFE-A665F7F87C32Q40097963-B4B036BD-2010-40E1-B256-C9F0A46D2A90Q40274752-987CAF23-0B4B-4610-8E12-3BFE1F8EA2C1Q40631581-17E7AEC2-4F4F-4655-ACAE-963B66028127Q44138046-526EA0CE-3A5A-41DF-A3FF-FCF0A0AD7968Q44897638-2A8D2624-3905-4776-998A-F68DA770E68DQ46326634-AA10C8B0-0999-4743-8905-D9422CCBA746Q47629968-A07E4159-482F-413E-A640-1D04E00F22C4Q48124478-4D485B2D-710A-4C3C-8CCF-AC1AB9B9784EQ48244578-203AEDDB-3076-4D38-9CAA-9D2723C19E66
P2860
Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@ast
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@en
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@nl
type
label
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@ast
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@en
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@nl
prefLabel
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@ast
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@en
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@nl
P2093
P2860
P1476
Pregnancy of unknown location: ...... ure, definitions, and outcome.
@en
P2093
Ben Van Calster
Ben Willem Mol
Cecilia Bottomley
Dirk Timmerman
George Condous
Karine Chung
Katherine L O'Flynn O'Brien
Kurt Barnhart
Mary Sammel
P2860
P304
P356
10.1016/J.FERTNSTERT.2010.09.006
P407
P577
2010-10-14T00:00:00Z